Claims for GH as an anti-aging treatment date back to 1990 when the New England Journal of Medicine published a study wherein GH was used to treat 12 men over 60.  At the conclusion of the study, all the men showed statistically significant increases in lean body mass and bone mineral density, while the control group did not. The authors of the study noted that these improvements were the opposite of the changes that would normally occur over a 10- to 20-year aging period. Despite the fact the authors at no time claimed that GH had reversed the aging process itself, their results were misinterpreted as indicating that GH is an effective anti-aging agent.    This has led to organizations such as the controversial American Academy of Anti-Aging Medicine promoting the use of this hormone as an "anti-aging agent". 
Recent studies have revealed effects of relaxin on other systems in the body. Relaxin decreases tissue fibrosis in the kidney , heart, lungs and liver, and promotes wound healing. Tissue fibrosis is the formation of hard tissue as a result of inflammation which can lead to scarring and loss of organ function. This has made relaxin of interest to scientists studying how the heart heals after it has been damaged, which may help to treat heart failure in the future. In addition, relaxin can influence blood pressure by relaxing blood vessels; promote the growth of new blood vessels; and is also anti-inflammatory. All of these properties could make it a potential therapeutic target for the treatment of certain diseases.